Sign in
Not yet taking people in United StatesPhase 4

Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

Key facts

Who runs it
Montefiore Medical Center
Where
New York, United StatesSee the site
Trial code
Status
Not yet recruiting
Phase
Phase 4
People taking part
200 people, planned
Started
Oct 2026
Expected to end
Oct 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Metoclopramide 10mg
  • Acetaminophen
Record updated
1 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Adults presenting to one of the study emergency departments (EDs)
  • Acute minor traumatic brain injury/concussion as defined by the Zurich Consensus Statement, including symptoms in somatic, cognitive, emotional, behavioral, physical, cognitive impairment, or sleep domains
  • ED visit occurring within 7 days of the head injury
  • Overall pain intensity greater than >=6 on a 0-10 scale
  • Rivermead Post-Concussion Questionnaire (RPQ) score of at least 10
  • Reported post-concussion symptoms were not present prior to the injury
  • Treating attending physician plans to administer a parenteral medication

Who cannot take part

  • Already treated with an anti-dopaminergic medication for post-concussion symptoms
  • Contraindications to study medications, including:
  • Use of monoamine oxidase (MAO) inhibitors
  • Use of anti-rejection transplant medications
  • Seizure disorder
  • Parkinson's disease
  • Pheochromocytoma
  • Pregnant patients will not be excluded because both acetaminophen and metoclopramide are commonly used during pregnancy

Where in United States

  • Montefiore Medical CenterNew York, United StatesContact: Hamed Sarikhani Assistant Professor of Emergency Medicine, MDNot yet recruiting

About the trial

What the trial wants to find out

The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for treating acute post-concussion symptoms in emergency department patients after mild head injury. The study aims to determine which treatment more effectively improves symptoms such as headache, dizziness, nausea, concentration difficulties, and emotional changes within the first week after injury.

Read full original descriptionShow less

Participants will be enrolled across two Montefiore emergency departments and followed using a validated post-concussion symptom questionnaire. Findings from this study may help improve evidence-based treatment strategies for patients experiencing concussion-related symptoms after head trauma.

The 2 groups in the trial

  • Metoclopramide 10 mgExisting treatment, for comparison

    Metoclopramide 10 mg IV over 15 minutes

    Treatment: Metoclopramide 10mg

  • AcetaminophenExisting treatment, for comparison

    1000 Mg IV over 15 minutes

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Study of Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment
Record updated
1 October 2026